Stanford Cancer Institute
Research facility
Location:
Stanford, CA,
United States (USA) (US)
ISNI: 0000000419368956
ROR: https://ror.org/00f54p054
Show on Map:
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome (2024)
Vinnakota JM, Biavasco F, Schwabenland M, Chhatbar C, Adams RC, Erny D, Duquesne S, et al.
Journal article
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2021)
Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindström S, Behrens S, Michailidou K, et al.
Journal article
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020)
Liu J, Prager-van der Smissen WJ, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, et al.
Journal article
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020)
Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, et al.
Journal article